CordenPharma
Jason Coleman is an experienced professional in the field of nanomedicine and drug delivery, currently serving as the Associate Platform Director for Lipids and LNP at Corden Pharma since February 2025. Previously, Jason held various leadership roles at Cytiva and Precision NanoSystems Inc., where responsibilities included leading global field application scientist teams and developing nanoparticle-based formulations for clinical applications. With a strong foundation in pharmaceutical R&D from iCeutica, Jason advanced proprietary technologies to enhance drug bioavailability. Early career experience includes post-doctoral research at Temple University focused on targeted drug delivery systems. Jason holds a Ph.D. in Chemical & Biological Engineering and a Master’s in Biomedical Engineering, both from Drexel University.
This person is not in any teams
This person is not in any offices
CordenPharma
1 followers
CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Lipid Excipients, Drug Products and Packaging. Through a network of cGMP facilities across Europe and the US organized under six technology platforms – Peptides, Lipids & Carbohydrates, Oligonucleotides, Injectables, Highly Potent & Oncology, Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value pharmaceutical products. Visit to learn more > cordenpharma.com